Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12755 | 883 | 30.5 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
12755 | 1 | LEVETIRACETAM//SV2A//BRIVARACETAM | 883 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LEVETIRACETAM | authKW | 8929136 | 57% | 52% | 501 |
2 | SV2A | authKW | 1067027 | 4% | 86% | 36 |
3 | BRIVARACETAM | authKW | 1031277 | 4% | 76% | 39 |
4 | KEPPRA | authKW | 539880 | 2% | 71% | 22 |
5 | SYNAPTIC VESICLE PROTEIN 2A | authKW | 380379 | 1% | 100% | 11 |
6 | ANTIEPILEPTIC DRUGS | authKW | 316135 | 20% | 5% | 178 |
7 | UCB L059 | authKW | 311219 | 1% | 100% | 9 |
8 | LEVETIRACETAM LEV | authKW | 276639 | 1% | 100% | 8 |
9 | UCB 34714 | authKW | 242059 | 1% | 100% | 7 |
10 | LEVETIRACETAM KEPPRA | authKW | 177838 | 1% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 14147 | 55% | 0% | 483 |
2 | Neurosciences | 1185 | 23% | 0% | 203 |
3 | Pharmacology & Pharmacy | 1057 | 22% | 0% | 194 |
4 | Psychiatry | 523 | 10% | 0% | 86 |
5 | Behavioral Sciences | 379 | 5% | 0% | 45 |
6 | Pediatrics | 318 | 7% | 0% | 66 |
7 | Medical Laboratory Technology | 47 | 1% | 0% | 13 |
8 | Toxicology | 32 | 3% | 0% | 23 |
9 | Chemistry, Analytical | 8 | 3% | 0% | 26 |
10 | Anesthesiology | 8 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMA SECTOR | 169359 | 2% | 29% | 17 |
2 | PHARMACOL THER EUT UNIT | 109295 | 2% | 23% | 14 |
3 | PRECLIN CNS | 79919 | 2% | 14% | 17 |
4 | GLOBAL PHARMACOMET | 69160 | 0% | 100% | 2 |
5 | UCB CNS INNOVAT | 69160 | 0% | 100% | 2 |
6 | UCB PHARMA SECTOR | 69160 | 0% | 100% | 2 |
7 | UCB SA PHARMA SECT | 69160 | 0% | 100% | 2 |
8 | CHEMIN FORIEST | 69152 | 1% | 33% | 6 |
9 | CHEM FORIEST | 51867 | 0% | 50% | 3 |
10 | PHARMA SECTOR DEV | 46105 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 60171 | 7% | 3% | 65 |
2 | EPILEPSY RESEARCH | 33215 | 7% | 2% | 61 |
3 | EPILEPSIA | 28031 | 10% | 1% | 85 |
4 | EPILEPTIC DISORDERS | 15103 | 2% | 2% | 21 |
5 | EPILEPSY & BEHAVIOR | 12209 | 4% | 1% | 38 |
6 | EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY | 5277 | 1% | 1% | 13 |
7 | ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2370 | 1% | 1% | 12 |
8 | JOURNAL OF CHILD NEUROLOGY | 2284 | 2% | 0% | 18 |
9 | PEDIATRIC NEUROLOGY | 1815 | 2% | 0% | 15 |
10 | FRONTIERS IN NEUROLOGY | 1311 | 1% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LEVETIRACETAM | 8929136 | 57% | 52% | 501 | Search LEVETIRACETAM | Search LEVETIRACETAM |
2 | SV2A | 1067027 | 4% | 86% | 36 | Search SV2A | Search SV2A |
3 | BRIVARACETAM | 1031277 | 4% | 76% | 39 | Search BRIVARACETAM | Search BRIVARACETAM |
4 | KEPPRA | 539880 | 2% | 71% | 22 | Search KEPPRA | Search KEPPRA |
5 | SYNAPTIC VESICLE PROTEIN 2A | 380379 | 1% | 100% | 11 | Search SYNAPTIC+VESICLE+PROTEIN+2A | Search SYNAPTIC+VESICLE+PROTEIN+2A |
6 | ANTIEPILEPTIC DRUGS | 316135 | 20% | 5% | 178 | Search ANTIEPILEPTIC+DRUGS | Search ANTIEPILEPTIC+DRUGS |
7 | UCB L059 | 311219 | 1% | 100% | 9 | Search UCB+L059 | Search UCB+L059 |
8 | LEVETIRACETAM LEV | 276639 | 1% | 100% | 8 | Search LEVETIRACETAM+LEV | Search LEVETIRACETAM+LEV |
9 | UCB 34714 | 242059 | 1% | 100% | 7 | Search UCB+34714 | Search UCB+34714 |
10 | LEVETIRACETAM KEPPRA | 177838 | 1% | 86% | 6 | Search LEVETIRACETAM+KEPPRA | Search LEVETIRACETAM+KEPPRA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LYSENG-WILLIAMSON, KA , (2011) LEVETIRACETAM A REVIEW OF ITS USE IN EPILEPSY.DRUGS. VOL. 71. ISSUE 4. P. 489 -514 | 76 | 66% | 59 |
2 | LOSCHER, W , GILLARD, M , SANDS, ZA , KAMINSKI, RM , KLITGAARD, H , (2016) SYNAPTIC VESICLE GLYCOPROTEIN 2A LIGANDS IN THE TREATMENT OF EPILEPSY AND BEYOND.CNS DRUGS. VOL. 30. ISSUE 11. P. 1055 -1077 | 86 | 60% | 0 |
3 | ABOU-KHALIL, B , (2005) BENEFIT-RISK ASSESSMENT OF LEVETIRACETAM IN THE TREATMENT OF PARTIAL SEIZURES.DRUG SAFETY. VOL. 28. ISSUE 10. P. 871 -890 | 80 | 75% | 26 |
4 | KLITGAARD, H , MATAGNE, A , NICOLAS, JM , GILLARD, M , LAMBERTY, Y , DE RYCK, M , KAMINSKI, RM , LECLERCQ, K , NIESPODZIANY, I , WOLFF, C , ET AL (2016) BRIVARACETAM: RATIONALE FOR DISCOVERY AND PRECLINICAL PROFILE OF A SELECTIVE SV2A LIGAND FOR EPILEPSY TREATMENT.EPILEPSIA. VOL. 57. ISSUE 4. P. 538 -548 | 43 | 74% | 7 |
5 | CREPEAU, AZ , TREIMAN, DM , (2010) LEVETIRACETAM: A COMPREHENSIVE REVIEW.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 10. ISSUE 2. P. 159 -171 | 62 | 67% | 42 |
6 | CARRENO, M , (2007) LEVETIRACETAM.DRUGS OF TODAY. VOL. 43. ISSUE 11. P. 769-794 | 73 | 66% | 16 |
7 | DE SMEDT, T , RAEDT, R , VONCK, K , BOON, P , (2007) LEVETIRACETAM: THE PROFILE OF A NOVEL ANTICONVULSANT DRUG - PART I: PRECLINICAL DATA.CNS DRUG REVIEWS. VOL. 13. ISSUE 1. P. 43-56 | 59 | 75% | 32 |
8 | CORMIER, J , CHU, CJ , (2013) SAFETY AND EFFICACY OF LEVETIRACETAM FOR THE TREATMENT OF PARTIAL ONSET SEIZURES IN CHILDREN FROM ONE MONTH OF AGE.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 9. ISSUE . P. 295-306 | 52 | 71% | 8 |
9 | ZACCARA, G , (2016) BRIVARACETAM: NEW COMPOUND APPROVED FOR THE TREATMENT OF EPILEPSY.DRUGS OF TODAY. VOL. 52. ISSUE 4. P. 219 -227 | 47 | 76% | 0 |
10 | FAROOQ, MU , BHATT, A , MAJID, A , GUPTA, R , KHASNIS, A , KASSAB, MY , (2009) LEVETIRACETAM FOR MANAGING NEUROLOGIC AND PSYCHIATRIC DISORDERS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 66. ISSUE 6. P. 541-561 | 59 | 63% | 26 |
Classes with closest relation at Level 1 |